Market Overview:
The global furazolidone market is expected to register a CAGR of 3.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing demand for furazolidone from the pharmaceutical and industrial applications. Furazolidone is used as an antibacterial agent in various applications such as pharmacy, food & beverage, and personal care products. North America dominates the global furazolidone market due to high demand from pharmaceutical and industrial sectors in this region.
Product Definition:
Furazolidone is an antibiotic used to treat a number of bacterial infections, including diarrhea caused by Clostridium difficile. It is also used to prevent travelers' diarrhea.
Pharma Grade:
It is a colorless and highly water-soluble crystalline compound, which is soluble in diethyl ether, acetone and ethanol. It has a slight odor like other members of the group. The commercial product consists of 99%+ pure substance with an average molecular weight of about 140 Da.
The global pharma-grade furazolidone market size was valued at USD 11 million in 2016.
Industrial Grade:
Industrial grade is a high purity form of the drug and it has been manufactured by evaporating the water from a molten mixture of furazolidone and propylene. It contains 99% or more of active ingredient as compared to Pharmaceutical Grade Furazolidone which contains less than 90%. Industrial grade Furazolidone also has higher melting point as compared to its counterpart, which makes it ideal for industrial applications.
Application Insights:
The industry application segment led the global furazolidone market in 2017 and is projected to expand at a CAGR of XX% over the forecast period. The growth can be attributed to increasing demand for pharmaceutical-grade products from developed countries such as Germany, U.K., France and Spain due to stringent regulations regarding drug quality imposed by these countries.
Pharmacy application accounted for more than half of the overall revenue share in 2017 owing to high product usage in manufacturing generic drugs including furazolidone, phenprocoumon, doxycycline hyclate, amoxicillin trihydrate & clavulanate potassium salt among others which are used for various indications such as urinary tract infections (UTIs), bronchitis & pneumonia etc.
Regional Analysis:
North America was the leading regional market in 2017 and is anticipated to maintain its position during the forecast period. The growth of this region can be attributed to rising product demand from various end-use industries, such as pharmaceuticals and chemical manufacturing. Furazolidone is used as a raw material for producing other chemicals, such as formaldehyde and methanol. Thus, increasing demand for these products has led to an increase in furazolidone consumption in North America over the past few years.
Asia Pacific emerged as one of the fastest-growing regions with a CAGR of XX% from 2018 to 2030 owing to rapid industrialization along with growing healthcare spending by countries like China and India that are major consumers of furazolidone due to high production volume coupled with low costs associated with its production compared to Europe or North America.
Growth Factors:
- Increasing prevalence of infectious diseases: The increasing prevalence of infectious diseases is one of the major growth drivers for the furazolidone market. Furazolidone is an effective drug against a wide range of bacterial infections, which is expected to drive its demand in the coming years.
- Rising awareness about antimicrobial resistance: The rising awareness about antimicrobial resistance and its implications on human health is another key factor that would fuel the demand for furazolidone in the coming years.
- Growing number of clinical studies supporting its use: A growing number of clinical studies supporting the use of furazolidone as an effective drug against various bacterial infections would further boost its demand in the near future.
- Launch of new formulations and products: The launchof new formulations and products by key players operating in this market would provide impetus tothe growth prospectsoffurazolidonein themarketplaceinthecomingyears.
Scope Of The Report
Report Attributes
Report Details
Report Title
Furazolidone Market Research Report
By Type
Pharma Grade, Industrial Grade, Others
By Application
Pharmacy, Industry
By Companies
Becton, Dickinson and Company (BD), Daiichi Sankyo, GrÜNenthal Gmbh, Standpharm, Teva, Marvi, Ferring, Geo-Med, KPL Pharma, Keyfarm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
135
Number of Tables & Figures
95
Customization Available
Yes, the report can be customized as per your need.
Global Furazolidone Market Report Segments:
The global Furazolidone market is segmented on the basis of:
Types
Pharma Grade, Industrial Grade, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmacy, Industry
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Becton, Dickinson and Company (BD)
- Daiichi Sankyo
- GrÜNenthal Gmbh
- Standpharm
- Teva
- Marvi
- Ferring
- Geo-Med
- KPL Pharma
- Keyfarm
Highlights of The Furazolidone Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pharma Grade
- Industrial Grade
- Others
- By Application:
- Pharmacy
- Industry
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Furazolidone Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Furazolidone is a medication used to treat anxiety and panic disorders. It works by decreasing the activity of certain nerve cells in the brain.
Some of the key players operating in the furazolidone market are Becton, Dickinson and Company (BD), Daiichi Sankyo, GrœNenthal Gmbh, Standpharm, Teva, Marvi, Ferring, Geo-Med, KPL Pharma, Keyfarm.
The furazolidone market is expected to grow at a compound annual growth rate of 3.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Furazolidone Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Furazolidone Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Furazolidone Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Furazolidone Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Furazolidone Market Size & Forecast, 2018-2028
4.5.1 Furazolidone Market Size and Y-o-Y Growth
4.5.2 Furazolidone Market Absolute $ Opportunity
Chapter 5 Global Furazolidone Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Furazolidone Market Size Forecast by Type
5.2.1 Pharma Grade
5.2.2 Industrial Grade
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Furazolidone Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Furazolidone Market Size Forecast by Applications
6.2.1 Pharmacy
6.2.2 Industry
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Furazolidone Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Furazolidone Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Furazolidone Analysis and Forecast
9.1 Introduction
9.2 North America Furazolidone Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Furazolidone Market Size Forecast by Type
9.6.1 Pharma Grade
9.6.2 Industrial Grade
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Furazolidone Market Size Forecast by Applications
9.10.1 Pharmacy
9.10.2 Industry
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Furazolidone Analysis and Forecast
10.1 Introduction
10.2 Europe Furazolidone Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Furazolidone Market Size Forecast by Type
10.6.1 Pharma Grade
10.6.2 Industrial Grade
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Furazolidone Market Size Forecast by Applications
10.10.1 Pharmacy
10.10.2 Industry
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Furazolidone Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Furazolidone Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Furazolidone Market Size Forecast by Type
11.6.1 Pharma Grade
11.6.2 Industrial Grade
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Furazolidone Market Size Forecast by Applications
11.10.1 Pharmacy
11.10.2 Industry
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Furazolidone Analysis and Forecast
12.1 Introduction
12.2 Latin America Furazolidone Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Furazolidone Market Size Forecast by Type
12.6.1 Pharma Grade
12.6.2 Industrial Grade
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Furazolidone Market Size Forecast by Applications
12.10.1 Pharmacy
12.10.2 Industry
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Furazolidone Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Furazolidone Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Furazolidone Market Size Forecast by Type
13.6.1 Pharma Grade
13.6.2 Industrial Grade
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Furazolidone Market Size Forecast by Applications
13.10.1 Pharmacy
13.10.2 Industry
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Furazolidone Market: Competitive Dashboard
14.2 Global Furazolidone Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Becton, Dickinson and Company (BD)
14.3.2 Daiichi Sankyo
14.3.3 GrÜNenthal Gmbh
14.3.4 Standpharm
14.3.5 Teva
14.3.6 Marvi
14.3.7 Ferring
14.3.8 Geo-Med
14.3.9 KPL Pharma
14.3.10 Keyfarm
